Sibylla Biotech

Curated by Signal

AI-powered platform for drug discovery

Overview

AI-powered platform for drug discovery. The company's approach, named "Pharmacological protein Inactivation by Folding Intermediates Targeting" (PPI-FIT), allows them to identify and develop small molecules acting on targets involved in different types of diseases. It's pipeline currently focuses on Cyclin D1 and KRAS as the main targets for oncology and inflammatory diseases.

Key facts

Founded: 2017
Headquarters: Trento, Italy
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

WeGlad
Digital transportation system for disabled individuals
Health TechnologyTurin, Italy
Mindwork
Online platform offering psychological wellness services to businesses
Health TechnologyMilan, Italy
WikiPharm
Provider of mobile applications for users to book a range of healthcare services
Health TechnologyMilan, Italy

About Sibylla Biotech

What does Sibylla Biotech do?

AI-powered platform for drug discovery.

Where is Sibylla Biotech headquartered?

Sibylla Biotech is headquartered in Trento, Italy.

When was Sibylla Biotech founded?

Sibylla Biotech was founded in 2017.

Which sector is Sibylla Biotech in?

Sibylla Biotech operates in Health Technology.

Who are Sibylla Biotech's competitors?

Companies similar to Sibylla Biotech include WeGlad, Mindwork, and WikiPharm.